Vinblastine Sulfate

CAS 143-67-9 3 current records 3 historicalSmall Molecule

Who holds supplier records for Vinblastine Sulfate? 3 organisations hold a current record for Vinblastine Sulfate: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Belgium (1) and Hungary (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Vinblastine Sulfate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/vinblastine-sulfate

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Vinblastine Sulfate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Belgium1Hungary1Country not recorded for 1
  • MINAKEM HIGH POTENT
    Active DMF 5335 · latest filing Apr 1984
    BelgiumCEP
  • HUBEI HONCH PHARMACEUTICAL CO LTD
    Active DMF 39944 · latest filing Jan 2025
    Company GMP cert on record
  • HungaryCEP Company GMP cert on record
Need Vinblastine Sulfate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Vinblastine Sulfate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
MINAKEM HIGH POTENT Mont-Saint-GuibertBE
CEP 2020-065 - Rev 02
Vinblastine Sulfate, Process 2
Dec 2025—
GEDEON RICHTER PLC. BudapestHU
R1-CEP 2005-261 - Rev 00
Vinblastine Sulfate
Nov 2011—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Vinblastine Sulfate are no longer active. These show a past filing, not current supply.

Show all 3 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Vinblastine Sulfate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL378544).

Chemical identity

IUPAC name
methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid
Canonical SMILES
CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O
InChIKey
KDQAABAKXDWYSZ-PNYVAJAMSA-N
Synonyms
29060-LE, 29060LE, Alkaban-aq, NSC-49842, Velban, Velbe, Vinblastine sulfate, Vinblastine sulphate, Vinblastini sulfas, Vinblast,lederle, Vincaleukoblastine sulfate, Vlb monosulfate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Vinca Alkaloid
Chemical structure
Vinca Alkaloids

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Vinblastine Sulfate?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Vinblastine Sulfate: MINAKEM HIGH POTENT (Belgium), HUBEI HONCH PHARMACEUTICAL CO LTD and Gedeon Richter (Hungary). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Vinblastine Sulfate Drug Master Files are active?

MINAKEM HIGH POTENT (DMF 5335) and HUBEI HONCH PHARMACEUTICAL CO LTD (DMF 39944). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Vinblastine Sulfate records mean?

3 organisations have only inactive Type II DMFs for Vinblastine Sulfate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Vinblastine Sulfate have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Vinblastine Sulfate on the EDQM register, including MINAKEM HIGH POTENT Mont-Saint-Guibert (BE) and GEDEON RICHTER PLC. Budapest (HU). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Vinblastine Sulfate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Vinblastine Sulfate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.